BP1078

5-甲氧基色胺

British Pharmacopoeia (BP) Reference Standard

• 别名: 2-(5-甲氧基吲唑-3-基)乙胺, 3-(2-氨基乙基)-5-甲氧基吲哚, 5-MOT, 5-甲氧基吲哚-3-乙胺, NSC 56422, 去乙酰褪黑素
• 经验公式（希尔记法）: C₁₁H₁₄N₂O
• CAS号: 608-07-1
• 分子量: 190.24
• Beilstein: 145587
• MDL號碼: MFCD00005662
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: melatonin
• 形狀: solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• mp: 121-123 °C (lit.)
• 應用: pharmaceutical; pharmaceutical small molecule
• 形式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: COc1ccc2[nH]cc(CCN)c2c1
• InChI: 1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3
• InChI 密鑰: JTEJPPKMYBDEMY-UHFFFAOYSA-N

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

用于制备以下物质的反应物：

• shishijimicin A的咔啉二糖结构域
• 褪黑激素类似物用于降低眼压
• 5-HT4受体配体
• 分选酶A和异柠檬酸裂解酶的抑制剂
• 用于治疗缺血/再灌注（I/R）损伤的治疗剂
• Aurora和表皮生长因子受体激酶抑制剂
• 用于治疗人乳头瘤病毒感染的药剂
• Manzamine类似物用于控制神经炎症和脑部感染
• 促炎细胞因子的抑制剂
• Tacrine-melatonin杂合物作为阿尔茨海默病的多功能药物

5-Methoxytryptamine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Melatonin Capsules

包裝

Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302
• 防範說明: P264 - P270 - P301 + P312 - P501
• 危險分類: Acute Tox. 4 Oral
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable